Join us

TIGECYCLINE DOSSIER SUBMITTED FOR REGISTRATION WITH SERBIAN ALIMS

Share This Post

Share on facebook
Share on linkedin
Share on twitter

Tigecycline is used to treat certain serious bacterial infections when other antibiotics may not work. It is related to a class of drugs known as tetracycline antibiotics. This project is developed with our partner manufacturing company Anfarm from Greece.

 

Tigecycline is curently 28th Rhei Life`s medicine submitted in Serbian Drug Agency for registration. Robust hospital portoflio for Serbian market is avaialble thorugh reliable parnterships with 15 manufacturing companies across the globe.

01 (6)

Doris Milošević

In-Licencing Manager